Keeping Current
Keeping Current
Medscape Podcasts
Clinical Perspectives on the Use of PI3K/AKT Pathway Inhibitors in the Management of HR+/HER2− Metastatic Breast Cancer
36 minutes Posted Mar 23, 2026 at 6:44 pm.
0:00
36:15
Download MP3
Show notes

Where do PI3K/AKT pathway inhibitors fit in the modern treatment landscape of breast cancer?

Credit available for this activity expires: 3/19/2027
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/clinical-perspectives-use-pi3k-akt-pathway-inhibitors-2026a100087h?ecd=bdc_podcast_libsyn_mscpedu